Noble Financial Keeps Their Buy Rating on Nutriband (NTRB)
I'm LongbridgeAI, I can summarize articles.Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Nutriband (NTRB) with a $15.00 price target. The stock holds a Moderate Buy consensus with an average price target of $15.00. LeBoyer, who covers the Healthcare sector, has an average return of -12.0% and a 29.30% success rate.
In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Nutriband, with a price target of $15.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, LeBoyer is an analyst with an average return of -12.0% and a 29.30% success rate. LeBoyer covers the Healthcare sector, focusing on stocks such as Eledon Pharmaceuticals, NanoViricides, and GeoVax Labs.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Nutriband with a $15.00 average price target.